Literature DB >> 8841653

Modelling and design of cross-over trials.

B Jones1, A N Donev.   

Abstract

There are many diseases and conditions that can be studied using a cross-over clinical trial, where the subjects receive sequences of treatments. The treatments are then compared using the repeated measurements taken 'within' subjects. The actual plan or design of the trial is usually obtained by consulting a published table of designs or by applying relatively simple rules such as using all possible permutations of the treatments. However, there is a danger is this approach because the model assumed for the data when the tables or rules were constructed may not be appropriate for the new trial being planned. Also, there may be restrictions in the new trial on the number of treatment sequences that can be used or on the number of periods of treatment particular subjects can be given. Such restrictions may mean that a published design of the ideal size cannot be found unless compromises are made. A better approach is to make the design satisfy the objectives of the trial rather than vice versa. In this paper we describe an approach to constructing such tailor-made designs which we hope will lead to ill-fitting 'off the peg' designs being a thing of the past. We use a computer algorithm to search for optimal designs and illustrate it using a number of examples. The criterion of optimality used in this paper is A-optimality but our approach is not restricted to one particular criterion. The model used in the search for the optimal design is chosen to suit the nature of the trial at hand and as an example a variety of models for three treatments are considered. We also illustrate the construction of designs for the comparison of two active treatments and a placebo where it can be assumed that the carry-over effects of the active treatments are similar. Finally, we illustrate an augmentation of a design that could arise when the objectives of a trial change.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841653     DOI: 10.1002/(SICI)1097-0258(19960715)15:13<1435::AID-SIM278>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Evaluation of an architecture for intelligent query and exploration of time-oriented clinical data.

Authors:  Susana B Martins; Yuval Shahar; Dina Goren-Bar; Maya Galperin; Herbert Kaizer; Lawrence V Basso; Deborah McNaughton; Mary K Goldstein
Journal:  Artif Intell Med       Date:  2008-04-28       Impact factor: 5.326

2.  Novel methods for the analysis of stepped wedge cluster randomized trials.

Authors:  Lee Kennedy-Shaffer; Victor de Gruttola; Marc Lipsitch
Journal:  Stat Med       Date:  2019-12-26       Impact factor: 2.373

3.  A note on point estimation and interval estimation of the relative treatment effect under a simple crossover design.

Authors:  Chii-Dean Lin; Kung-Jong Lui
Journal:  Pharm Stat       Date:  2021-11-09       Impact factor: 1.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.